References
- Manguso F, Balzano A. Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs 5-aminosalicylic acid in mild to moderate distal ulcerative colitis. Aliment Pharmacol Ther 2007; 26: 21–9
- Biancone L, Gionchetti P, Del Vecchio Blanco G, Orlando A, Annese V, Papi C. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomised, double-blind study. Dig Liver Dis 2007; 39: 329–37
- Campieri M, Cottone M, Miglio F, Manenti F, Astegiano M, D'Arienzo A. Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis. Aliment Pharmacol Ther 1998; 12: 361–6
- Banski G, Bulher H, Stamm B, Hacki WH, Buchmann P, Muller J. Treatment of distal ulcerative colitis with beclomethasone enemas: high therapeutic efficacy without endocrine side-effects. Dis Colon Rectum 1987; 30: 288–92
- Mulder CJJ, Fockens P, Meijer JW, Van der Heide H, Wiltink HH, Tytgat GNJ. Beclomethasone dipropionate (3 mg) versus. 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active distal ulcerative colitis. Eur J Gastroenterol Hepatol 1996;8:549–53.